NPT520-34   Click here for help

GtoPdb Ligand ID: 13271

Synonyms: compound 1 [WO2019246454]
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: NPT520-34 is a small molecule clinical lead with potential efficacy in neurodegenerative disorders [2]. Preclinical evidence shows that NPT520-34 clears neurotoxic protein aggregates and reduces inflammation. The direct molecular target(s) of NPT520-34 have not been identified, but experimental data support enhanced protein clearance by autophagy. Screening against a broad panel of protein targets identified NPT520-34 as an inhibitor of the solute carrier organic ion transporter organic anion transporter 3 (OAT3; SLC22A8), and this is confirmed by claim of this compound as an anti-neurodegeneration OAT3 inhibitor in patent WO2019246454A1 [1]. The physiological relevance of this remains to be confirmed.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 102.24
Molecular weight 419.83
XLogP 3.05
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C1=C(C=CC(=C1)S(=O)(=O)C2=CC=C(C(=C2)C(F)(F)F)Cl)N3C=NNC3=S
Isomeric SMILES FC(F)(F)C1=C(Cl)C=CC(=C1)S(=O)(=O)C2=CC=C(C=C2)N3C=NNC3=S
InChI InChI=1S/C15H9ClF3N3O2S2/c16-13-6-5-11(7-12(13)15(17,18)19)26(23,24)10-3-1-9(2-4-10)22-8-20-21-14(22)25/h1-8H,(H,21,25)
InChI Key BJWHWZOMLHXKPF-UHFFFAOYSA-N
Bioactivity Comments
NPT520-34 promotes α-synuclein clearance in vitro and reduces α-synuclein pathology and neuroinflammation in a transgenic mouse PD model. The PD mice treated with NPT520-34 showed improvements in motor function markers.
Selectivity at transporters
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
Organic anion transporter 3 Hs Inhibitor Inhibition 6.6 pIC50 - 2
pIC50 6.6 (IC50 2.5x10-7 M) [2]
Description: Measuring inhibition of [3H]-PAH transport by hOAT3.